Quantitative CT Imaging Parameters for Assessing Hepatic Steatosis in CHB
Utility of Quantitative Imaging Parameters from Deep Learning-based CT Segmentation in Assessing Hepatic Steatosis and Fibrosis in Chronic Hepatitis B: a Prospective Study Using MRI As the Reference Standard
2 other identifiers
observational
111
1 country
1
Brief Summary
This study aims to evaluate diagnostic performance of CT attenuation parameters acquired using deep learning algorithm in assessing hepatic steatosis and fibrosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2024
CompletedStudy Start
First participant enrolled
September 26, 2024
CompletedFirst Posted
Study publicly available on registry
September 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedSeptember 27, 2024
September 1, 2024
11 months
September 19, 2024
September 24, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
diagnostic performance of CT attenuatio parameters in assessing hepatic steatosis and fibrosis
diagnostic performance of CT attenuatio parameters in assessing hepatic steatosis and fibrosis using MRI-PDFF and MR elastography as reference standards
At the time of enrollment
Secondary Outcomes (1)
Consistency between MRI-derived body composition data and CT-derived data
At the time of enrollment
Interventions
noncontrast abdominal CT
Eligibility Criteria
Patients with chronic hepatitis B who follow up at Seoul National University Hospital having no history of hepatic malignancies
You may qualify if:
- chronic hepatitis B
- no chronic liver disease other than chronic hepatitis B
- Body mass index \>= 23
You may not qualify if:
- pregnant women
- unable to perform MRI examinations due to claustrophobia or metallic foreign body
- suspicious hepatic malignancy on previous imaging studies
- history of local treatment for hepatic lesions
- history of surgery or catheter insertion of liver or spleen
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, 03080, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical assistant professor
Study Record Dates
First Submitted
September 19, 2024
First Posted
September 27, 2024
Study Start
September 26, 2024
Primary Completion
August 31, 2025
Study Completion
August 31, 2025
Last Updated
September 27, 2024
Record last verified: 2024-09